# Nivolumab With or Without Ipilimumab or Chemotherapy in Treating Patients With Previously Untreated Stage I-IIIA Non-small Cell Lung Cancer

> **NCT03158129** · PHASE2 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 101 (actual)

## Conditions studied

- Stage I Lung Non-Small Cell Cancer AJCC v7
- Stage IA Lung Non-Small Cell Carcinoma AJCC v7
- Stage IB Lung Non-Small Cell Carcinoma AJCC v7
- Stage II Lung Non-Small Cell Cancer AJCC v7
- Stage IIA Lung Non-Small Cell Carcinoma AJCC v7
- Stage IIB Lung Non-Small Cell Carcinoma AJCC v7
- Stage IIIA Lung Non-Small Cell Cancer AJCC v7

## Interventions

- **DRUG:** Carboplatin
- **DRUG:** Cisplatin
- **DRUG:** Docetaxel
- **BIOLOGICAL:** Ipilimumab
- **BIOLOGICAL:** Nivolumab
- **DRUG:** Pemetrexed

## Key facts

- **NCT ID:** NCT03158129
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-16
- **Primary completion:** 2024-11-13
- **Final completion:** 2024-11-13
- **Target enrollment:** 101 (ACTUAL)
- **Last updated:** 2026-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03158129

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03158129, "Nivolumab With or Without Ipilimumab or Chemotherapy in Treating Patients With Previously Untreated Stage I-IIIA Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/clinical/NCT03158129. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*